Breast cancer remains the most frequently diagnosed cancer in women around the world, according to a new report. While deaths are dropping in the United States, they’re rising in poorer nations.
Soy Nómada on MSN
US cancer death rate drops 34%, but experts warn of troubling rise in these 3 cancers
The latest American Cancer Society report shows a 34% drop in cancer mortality since 1991, but reveals a worrying increase in ...
In 2026, an estimated 158,850 new cases of colorectal cancer (CRC) will be diagnosed, and 55,230 people will die from the ...
Add Yahoo as a preferred source to see more of our stories on Google. A new study from the American Cancer Society is shedding light on cancer mortality rates among young people — and the one type of ...
Breast cancer mortality has decreased in high-income countries but increased in lower-income ones — a stark divide in outcome in the most common cancer among women worldwide.
Cancer statistics have reached new heights — in good and not-so-good ways. The American Cancer Society (ACS) released its annual report on cancer trends this week, showing for the first time that more ...
The five-year cancer survival rate has reached 70%, driven by treatment advances, reduced smoking, and early detection, yet lung cancer remains the leading cause of cancer deaths. Disparities in ...
Diet, exercise and other healthy habits can lower your risk. Reviewed by Dietitian Katey Davidson, M.Sc.FN, RD, CPT Colorectal cancer deaths in people under 50 have risen 1.1% annually since 2005. It ...
While high-earning countries have seen a decline in breast cancer mortality, mainly due to investment in screening, ...
There's big cancer news this month. The American Cancer Society reports that for the first time, the five-year survival rate for all cancers combined reached 70%. That's for people diagnosed from 2015 ...
Breast cancer incidence is likely to continue to rise, experts project. They also highlight that almost one third of cases ...
Immune checkpoint inhibitors (ICIs) are immunotherapy drugs that mobilize the patient’s immune system to detect and attack cancer cells. They are considered a breakthrough development in cancer care, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results